Evidence map›Paper›PMID 40563643›Full record

ArticleCancers2025

Immune-Related Cutaneous Adverse Events Display Distinct Clinical and Molecular Characteristics, Depending on Immune Checkpoints Targeted.

Lukas Kraehenbuehl, Nicola Winkelbeiner, Patrick Turko, Ramon Staeger, Adhideb Ghosh, Vivienn Kaiser, Pia-Charlotte Stadler, Thierry M Nordmann, Marie-Charlotte Brüggen, Mitchell P Levesque and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Lukas KraehenbuehlDepartment of Dermatology and Allergology, Kantonsspital Aarau, 5001 Aarau, Switzerland.ORCID 0000-0001-5411-5661
Nicola WinkelbeinerFaculty of Medicine, Dermatology and Venereology, University of Zurich, 8006 Zurich, Switzerland.
Patrick TurkoDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-3695-8264
Ramon StaegerDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-9283-9596
Adhideb GhoshFaculty of Medicine, Dermatology and Venereology, University of Zurich, 8006 Zurich, Switzerland.ORCID 0000-0002-5160-4571
Vivienn KaiserDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Pia-Charlotte StadlerDepartment of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, 82152 Munich, Germany.
Thierry M NordmannDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.
Marie-Charlotte BrüggenDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-8607-6254
Mitchell P LevesqueDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-5902-9420
Emmanuel ContassotDepartment of Biomedicine, University of Basel, 4001 Basel, Switzerland.ORCID 0000-0002-3060-4644
Lars E FrenchDepartment of Dermatology and Allergy, University Hospital, LMU Munich, 81377 Munich, Germany.
Reinhard DummerDepartment of Dermatology and Allergology, Kantonsspital Aarau, 5001 Aarau, Switzerland.ORCID 0000-0002-2279-6906
Barbara Meier-SchiesserDepartment of Dermatology, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-2807-5066

Funding

Iten-Kohaut foundation n.a.University of Zurich and ETH (SKINTEGRITY.CH) n.a.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer immunotherapyimmune checkpoint inhibitionimmune-related adverse eventmelanomoncodermatology

Identifiers

PMID40563643
PMCPMC12190265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.